Study guide

22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis

IJCAHPO Certified Ophthalmic Medical Technologist COMT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The COMT Examination, Eligibility & Certification Requirements

1.1 The 190-Question Multiple-Choice Examination & the 22 Official Content Areas 1.2 The COT Skill Evaluation & the COMT Performance Test 1.3 Eligibility Pathways, Fees, Timelines & Recertification

2 Chapter 2: General Medical Knowledge I — Ocular Anatomy & Physiology

2.1 Orbit, Eyelids, Lacrimal System, Conjunctiva & Extraocular Muscles 2.2 Cornea, Sclera, Anterior Chamber, Angle, Aqueous Dynamics & Crystalline Lens 2.3 Uvea, Retina, Vitreous, Optic Nerve, Ocular Circulation & the Visual Pathway

3 Chapter 3: General Medical Knowledge II — Eye Disease, Systemic Manifestations, Terminology & Safety

3.1 Frequently Encountered Eye Conditions by Structure & Inflammation Versus Infection 3.2 Body Systems & the Ocular Manifestations of Systemic Disease 3.3 Medical Terminology, Approved Abbreviations, Hazardous Waste & Clinic Safety

4 Chapter 4: Ophthalmic History Taking & Clinical Documentation

4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family 4.2 Charting Conventions, Scribing & the Electronic Medical Record

5 Chapter 5: Visual Assessment, Accommodative Testing & Low Vision

5.1 Measuring Acuity at Every Level & in Preliterate, Illiterate and Non-Verbal Patients 5.2 Stereoacuity, Near Point of Accommodation, Near Point of Convergence & the AC/A Ratio 5.3 Low Vision Assessment, Magnification Calculation & Device Instruction

6 Chapter 6: Tonometry, Keratometry & Pupil Measurement

6.1 Goldmann Applanation Tonometry: Technique, Sources of Error & the Imbert-Fick Principle 6.2 Hand-Held Applanators, Non-Contact Tonometry, Rebound Tonometry & Disinfection 6.3 Manual & Automated Keratometry: Technique, Readings and Interpretation 6.4 Pupil Measurement, Shape, Reactivity & Evaluating Anisocoria

7 Chapter 7: Lensometry, Spectacle Optics & Prescription Analysis

7.1 Manual Lensometry: Eyepiece Focus, Neutralising Sphere, Cylinder & Axis 7.2 Neutralising Reading Adds: Bifocal, Trifocal, Progressive & Determining the Near Add 7.3 Identifying & Measuring Prism: Ground-In, Decentration, Fresnel Press-On & Slab-Off 7.4 Transposition, Spherical Equivalent, Vertex Distance & Prescription Components 7.5 The Geneva Lens Clock, Lens Materials, Progressive Markings & Spectacle Adjustment

8 Chapter 8: Refraction, Retinoscopy & Refinement

8.1 Autorefraction, Refractive Error Types & Establishing an Objective Starting Point 8.2 Streak Retinoscopy: With Motion, Against Motion, Neutralisation & Working Distance 8.3 Subjective Refinement: Fogging, Jackson Cross Cylinder, Duochrome & Binocular Balance 8.4 Near Add Determination, Vertex Recording & Refraction in Difficult Situations

9 Chapter 9: Ocular Motility, Strabismus & Advanced Optics

9.1 Ocular Kinematics: Ductions, Versions, Vergences, Hering's & Sherrington's Laws 9.2 Quantitative Strabismus Measurements: Alternate Cover Test, Prism Cover Test & Lancaster Red-Green / Hess Screen 9.3 Cranial Nerve Palsies (CN III, IV, VI), Restrictive Myopathies & Forced Duction Testing 9.4 Clinical Optics, Prentice's Rule, Slab-Off Prisms & Wavefront Aberrations

10 Chapter 10: Sensory Fusion Testing, Nystagmus, Amblyopia & Vergence Therapy

10.1 Sensory Fusion Testing: Worth 4-Dot, Maddox Rod & Bagolini Lenses 10.2 Hirschberg, Krimsky, Brückner & Fusional Vergence Amplitudes 10.3 Nystagmus, Amblyopia Therapy & Convergence Training

11 Chapter 11: Advanced Visual Fields & Neuro-Ophthalmic Evaluation

11.1 Amsler Grid & Confrontation Visual Field Testing 11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis 11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology 11.4 Kinetic Perimetry (Goldmann Perimetry) & Neurological Visual Pathway Defect Localization 11.5 Pupillary Pathways, RAPD Quantitation with Neutral Density Filters & Pharmacologic Testing

12 Chapter 12: Supplemental Testing — Glare, PAM, Colour Vision, Tear Film & Slit Lamp Technique

12.1 Glare Testing, Potential Acuity Meter & Contrast Sensitivity 12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test 12.3 Tear Film Assessment: Schirmer, Tear Break-Up Time, Vital Dyes & Corneal Sensitivity 12.4 Slit Lamp Technique, Slit Lamp Lenses, Direct Ophthalmoscopy & Pen Light Examination 12.5 Exophthalmometry, Head & Posture Assessment and Wavefront Diagnostics

13 Chapter 13: Full-Field Electroretinography & ISCEV Protocols

13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms 13.2 ISCEV Standard Full-Field ERG Protocol & Electrode Systems 13.3 Dark-Adapted (Scotopic) Testing: Rod-Driven Responses & Combined Maximal Response 13.4 Light-Adapted (Photopic) Testing: Cone Response, 30-Hz Flicker & Oscillatory Potentials

14 Chapter 14: Advanced Electrophysiologic Testing (mfERG, PERG, VEP, EOG)

14.1 Multifocal Electroretinogram (mfERG): Topographic Retinal Mapping 14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function 14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity 14.4 Electrooculogram (EOG), Arden Ratio & RPE Light Peak Dynamics

15 Chapter 15: Fluorescein Angiography Principles & Technique

15.1 Fluorescein Angiography Principles, Exciter/Barrier Filters & Injection Protocol 15.2 Normal Transit Phases & Retinal/Choroidal Circulation Hemodynamics 15.3 Adverse Reactions, Patient Safety & Emergency Management

16 Chapter 16: Angiographic Interpretation & Pathology

16.1 Hyperfluorescence Mechanisms: Leakage, Staining, Pooling, Window Defects & Autofluorescence 16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects 16.3 Indocyanine Green (ICG) Angiography: Principles, Indications & Choroidal Pathology

17 Chapter 17: Advanced Fundus Imaging & Optical Coherence Tomography

17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging 17.2 Spectral-Domain and Swept-Source OCT: Retinal Layer Architecture & Quantitative Analysis 17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT) 17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers

18 Chapter 18: Ophthalmic Photography & Videography

18.1 The Fundus Camera: Optics, Alignment & Correcting Artefacts 18.2 Standard Fundus Photography: ETDRS Fields, Stereo Pairs, Red-Free & Wide-Field Imaging 18.3 Slit Lamp & Anterior Segment Photography 18.4 External Photography, Nine-Gaze Motility Documentation & Image Management

19 Chapter 19: Ophthalmic Echography (A-Scan, B-Scan & UBM)

19.1 Physics of Ophthalmic Ultrasound, Acoustic Impedance & Probe Transducers 19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation 19.3 Diagnostic B-Scan Echography: Topographic, Kinetic & Quantitative Vitreoretinal Evaluation 19.4 Ultrasound Biomicroscopy (UBM): Anterior Segment Anatomy, Angle Pathology & Ciliary Body Imaging

20 Chapter 20: Biometry, Topography & Corneal Analysis

20.1 Optical Biometry vs. Immersion/Contact Ultrasound Biometry 20.2 Intraocular Lens (IOL) Power Calculation Formulas & Post-Refractive Adjustments 20.3 Corneal Topography, Scheimpflug Tomography & Keratoconus Screening 20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth

21 Chapter 21: Rigid Gas Permeable & Specialty Lens Fitting

21.1 Rigid Gas Permeable (RGP) Material Properties, Dk/t & Oxygen Permeability 21.2 RGP Base Curve Selection, Diagnostic Fitting & Fluorescein Pattern Evaluation 21.3 Scleral Contact Lens Design, Sagittal Depth Fitting & Clearance Evaluation 21.4 Keratoconus, Irregular Corneas & Hybrid Contact Lens Systems

22 Chapter 22: Toric, Multifocal, Therapeutic Lenses & Complications

22.1 Toric Soft Contact Lens Dynamics, Stabilization Techniques & LARS Rule 22.2 Presbyopic & Multifocal Contact Lens Systems: Simultaneous vs. Translating Designs 22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology 22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis

23 Chapter 23: Ocular Pharmacology

23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique 23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents 23.3 Glaucoma Medications: Classes, Mechanisms & Side Effects 23.4 Anti-Infectives, Corticosteroids, NSAIDs, Allergy Agents, Lubricants, Supplements & Anti-VEGF

24 Chapter 24: Microbiology & Ocular Specimen Collection

24.1 Types of Microorganisms & Pathways of Disease Transmission 24.2 Assisting with Conjunctival & Corneal Specimen Collection

25 Chapter 25: Anterior Segment, Glaucoma & Refractive Surgery

25.1 Advanced Phacoemulsification, Surgical Steps, Fluidics & Complication Management 25.2 Premium Intraocular Lenses: Toric, Multifocal, EDOF & Lens Exchange 25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices 25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs

26 Chapter 26: Vitreoretinal, Corneal & Trauma Surgery

26.1 Pars Plana Vitrectomy (PPV), Scleral Buckling & Intraocular Tamponades (Gas/Silicone Oil) 26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK) 26.3 Ocular Trauma Repair: Open Globe Management, Hyphema, Vitreous Loss & Endophthalmitis Protocol

27 Chapter 27: Surgical Asepsis, Instrumentation & Laser Procedures

27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions 27.2 Microsurgical Instrumentation, Maintenance & Sharps Safety 27.3 Ophthalmic Laser Physics, Delivery Systems & Safety (Nd:YAG, Argon/FD-Nd:YAG, SLT)

28 Chapter 28: Ophthalmic Patient Services & Education

28.1 Communicating with Patients, Families and Colleagues, and Handling Dissatisfaction 28.2 Patient Education & Counselling on Conditions, Medications, Tests and Results 28.3 Ophthalmic Emergencies, First Aid, Vital Signs & CPR 28.4 Triage, Urgency-Based Scheduling, Patient Flow & Telephone Management 28.5 Dressings and Shields, Prosthetics, Legal Forms, Referrals & Reimbursement Support

29 Chapter 29: Clinic Operations — Equipment Maintenance, Ethics, Coding & Compliance

29.1 Equipment Maintenance, Calibration, Emergency Equipment & Inventory 29.2 Confidentiality, Informed Consent, Scope of Practice & Ethical Standards 29.3 Coding, Scribing Compliance, Quality Assurance & Regulatory Requirements

22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis

Key Takeaways Explain This Topic AI

Giant Papillary Conjunctivitis (GPC/CLPC) is a combined mechanical and type I/IV immunological hypersensitivity reaction to denatured protein deposits on contact lenses, characterized by superior tarsal conjunctival cobblestone papillae > 1.0 mm.

Solution-induced corneal staining (SICS) occurs when cationic preservatives like PHMB release from the lens matrix to cause toxic epithelial death; accidental insertion of lenses with unneutralized 3% hydrogen peroxide causes catastrophic chemical desquamation.

Sterile inflammatory infiltrates (CLPU, CLARE) present with small (< 1.0 mm) peripheral infiltrates, intact or minimally stained epithelium, and absent anterior chamber reactions, contrasting sharply with sight-threatening microbial keratitis.

Pseudomonas aeruginosa produces elastase, alkaline protease, and exotoxin A, causing rapid stromal liquefaction, dense yellowish-green soup-like infiltrates, hypopyon, and corneal perforation within 24 to 48 hours.

Acanthamoeba keratitis is strongly linked to tap water exposure, presenting with agonizing pain out of proportion to early slit-lamp findings, radial keratoneuritis, and late pathognomonic stromal ring infiltrates.

Last updated: September 2026

Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis

Core Clinical Mandate: Contact lens wear alters the ocular microenvironment by reducing epithelial metabolic gas exchange, disrupting tear film dynamics, and introducing a synthetic surface for microbial biofilm adhesion. Certified Ophthalmic Medical Technologists (COMT) play a pivotal frontline role in triaging the contact lens patient presenting with an acute red eye. The technologist must instantly differentiate benign, self-limiting sterile inflammatory responses (CLARE, CLPU, toxic keratopathy) from fulminant, sight-threatening infectious keratitis ( Pseudomonas , Acanthamoeba , Fusarium ) that can melt the corneal stroma and cause globe perforation within 24 to 48 hours.

Giant Papillary Conjunctivitis (GPC / CLPC)

Giant Papillary Conjunctivitis (GPC) , also termed Contact Lens-Induced Papillary Conjunctivitis (CLPC) , is an inflammatory disorder of the superior tarsal conjunctiva provoked by contact lens wear, ocular prosthetics, or exposed surgical sutures.

Dual Etiology: Mechanical Friction & Immunological Hypersensitivity

GPC is not a simple friction rub; it is a multifactorial inflammatory disease involving both mechanical trauma and immune reactions:

Mechanical Microtrauma: The superior palpebral conjunctiva rubs across the lens edge and anterior surface approximately 10,000 to 15,000 times per day during normal blinking. High-modulus (stiff) silicone hydrogels exert greater physical shear against the tarsus than low-modulus hydrogels.

Type I (Immediate / IgE-Mediated) Hypersensitivity: Tear film proteins (lysozyme, lactoferrin, albumin) adhere to the contact lens matrix and become denatured by ambient air and temperature. These denatured proteins act as non-self antigens, triggering mast cell degranulation and histamine release in the tarsal conjunctiva.

Type IV (Delayed / Cell-Mediated) Hypersensitivity: Chronic exposure to denatured antigens stimulates T-helper lymphocytes, recruiting eosinophils, basophils, and mast cells into the substantia propria of the tarsal conjunctiva. Eosinophil major basic protein and inflammatory cytokines break down anchoring collagen septa, causing hypertrophic papillae to coalesce into giant structures. Immunological Cascade of GPC:

  • [Denatured Tear Proteins on Lens Polymer Matrix]
  • │
  • ▼
  • [Repetitive Upper Eyelid Mechanical Shear (15,000 blinks/day)]
  • │
  • ▼
  • [Breakdown of Conjunctival Epithelial Barrier]
  • │
  • ▼
  • [Antigen Presentation -> IgE Priming (Type I) + T-Cell Infiltration (Type IV)]
  • │
  • ▼
  • [Mast Cell Degranulation & Eosinophil Major Basic Protein Release]
  • │
  • ▼
  • [Collagen Septa Breakdown -> Hypertrophic Papillary Fusion (>1.0 mm 'Cobblestones')]
  • Clinical Staging and Slit-Lamp Examination

Eversion of the upper eyelid is mandatory in every contact lens patient during routine and emergency evaluations.

Grade 1 (Pre-Clinical): Mild tarsal hyperemia, uniform small micropapillae (< 0.3 mm). Patient reports mild morning mucus and faint foreign body sensation upon lens removal.

Grade 2 (Mild): Papillae measure 0.3 to 0.5 mm . Moderate conjunctival thickening obscuring underlying tarsal blood vessels. Patient notes reduced comfortable wearing time and lens awareness.

Grade 3 (Moderate): Papillae measure 0.5 to 1.0 mm with apical fluorescein staining. Heavy ropy mucus discharge. The lens decenters and rides excessively high on the cornea due to mechanical traction from the swollen tarsal conjunctiva.

Grade 4 (Severe / Giant): Pathognomonic "cobblestone" giant papillae measuring > 1.0 mm in diameter with flat, scarred tops. Severe mucus production, severe itching immediately upon lens removal, and total contact lens intolerance.

Clinical Management Protocol for GPC

Contact Lens Cessation: Mandatory complete cessation of contact lens wear until the tarsal conjunctiva becomes quiet and papillae flatten (typically 3 to 6 weeks).

Topical Mast Cell Stabilizer / Antihistamine Dual Agents: Topical olopatadine 0.2%–0.7%, alcaftadine 0.25%, or bepotastine 1.5% once or twice daily to stabilize mast cells and block H1 receptors.

Topical Corticosteroid Pulse Therapy: In Grade 3 or 4 GPC, initiate a short course of an ester-based "soft" topical corticosteroid with low intraocular pressure (IOP) elevation risk (e.g., loteprednol etabonate 0.5% or fluorometholone 0.1% qid for 2 weeks, then taper).

Refitting Strategy:

Transition to daily disposable contact lenses (eliminates the buildup of denatured protein antigens).

Transition from multipurpose solutions to preservative-free hydrogen peroxide systems .

If the patient must wear reusable lenses, refit into a low-modulus, ultra-smooth surface material.

Loading diagram... Clinical Triage Algorithm: Contact Lens Red Eye & Corneal Infiltrates

Contact Lens Solution Toxicity & Chemical Injury

Contact lens care systems rely on chemical formulations to disinfect and wet contact lens surfaces. However, interactions between chemical biocides and the corneal epithelium can induce severe toxic keratopathy.

Multipurpose Solution (MPS) Preservative Toxicity

Polyhexamethylene Biguanide (PHMB / Dymed / Polyaminopropyl Biguanide):

A cationic biocide that binds to negatively charged phospholipid bacterial membranes. However, PHMB also binds readily to modern silicone hydrogel lens matrices.

Solution-Induced Corneal Staining (SICS): During storage, the lens absorbs PHMB. When placed on the eye, the preservative desorbs rapidly from the lens into the pre-corneal tear film, reaching toxic concentrations. This induces diffuse, superficial punctate keratitis (SPK)—frequently in a characteristic annular (doughnut) ring configuration —peaking 2 to 4 hours after lens insertion. Patients present with burning, dryness, and reduced wearing tolerance.

Polyquaternium-1 (Polyquad) & Aldox: Large-molecule polymeric biocides that cannot penetrate the silicone hydrogel matrix as readily, producing substantially lower rates of SICS and corneal toxic staining.

Hydrogen Peroxide (3%) Disinfection Systems & Chemical Burns

Disinfection Mechanism: 3% unpreserved hydrogen peroxide ( H 2 O 2 H_2O_2 H 2 ​ O 2 ​ ) utilizes powerful oxidative free radicals to destroy bacteria, fungi, viruses, and Acanthamoeba trophozoites without chemical preservatives.

Catalytic Neutralization Mandate: Hydrogen peroxide is highly toxic to corneal epithelial cells. The system relies on a platinum-coated catalytic disc in the lens case (or an enzymatic catalase tablet) that converts toxic peroxide into neutral saline and oxygen: 2 H 2 O 2 → Platinum Catalyst 2 H 2 O + O 2 2\text{H}_2\text{O}_2 \xrightarrow{\text{Platinum Catalyst}} 2\text{H}_2\text{O} + \text{O}_2 2 H 2 ​ O 2 ​ Platinum Catalyst ​ 2 H 2 ​ O + O 2 ​

The 6-Hour Neutralization Rule: Complete neutralization requires a minimum immersion time of 6 continuous hours . If a patient removes the lens before 6 hours, unneutralized peroxide remains in the case.

Accidental Unneutralized Peroxide Chemical Burn:

Occurs when a patient inadvertently rinses a contact lens with H 2 O 2 H_2O_2 H 2 ​ O 2 ​ immediately before insertion, or inserts a lens before the 6-hour neutralization cycle finishes.

Clinical Picture: Instantaneous, excruciating, searing ocular pain, violent blepharospasm, conjunctival chemosis, and extensive punctate epithelial desquamation or total corneal epithelial sloughing.

Emergency Protocol: Immediately remove the lens. Copiously irrigate the eye with sterile saline or balanced salt solution (BSS) for 15 minutes. Instill topical preservative-free lubricants, a cycloplegic agent (cyclopentolate 1%) for ciliary spasm, and consider a prophylactic topical antibiotic. Reassure the patient that the epithelium will regenerate within 24 to 48 hours without stromal scarring.

Sterile Corneal Infiltrates vs. Infectious Microbial Keratitis

Differentiating non-infectious inflammatory infiltrates from true infectious microbial ulcers is one of the most critical responsibilities of the ophthalmic medical team.

Sterile Corneal Infiltrates (CLARE and CLPU)

Sterile infiltrates represent localized accumulations of polymorphonuclear neutrophils (PMNs) in the anterior corneal stroma in response to bacterial antigens, rather than live replicating bacteria within the stroma.

Contact Lens-Induced Acute Red Eye (CLARE):

Pathophysiology: Triggered by Gram-negative endotoxins (lipopolysaccharides) trapped beneath an immobile, tight contact lens during overnight sleep.

Clinical Picture: Patient awakens in the middle of the night with acute unilateral red eye, moderate pain, and photophobia. Slit lamp reveals diffuse conjunctival and ciliary injection with multiple small (0.1 to 0.5 mm) mid-peripheral or peripheral subepithelial infiltrates . Overlying epithelium is intact (no fluorescein pooling). No anterior chamber reaction .

Management: Discontinue contact lens wear. Condition resolves within 3 to 7 days with lubricating drops and refitting with a flatter base curve.

Contact Lens-Induced Peripheral Ulcer (CLPU):

Pathophysiology: Hypersensitivity reaction to Gram-positive exotoxins from Staphylococcus aureus colonizing the eyelid margins and lens surface.

Clinical Picture: A small, focal, circular, gray-white infiltrate ( < 1.0 mm in diameter ) located strictly in the peripheral cornea near the limbus . Overlying epithelium may display minimal punctate staining, but there is no deep stromal excavation, no anterior chamber reaction, and no hypopyon .

Sequela: Heals rapidly upon lens discontinuation, leaving a characteristic faint, circular, nummular corneal scar with an intact surface.

Clinical Distinction Matrix: Sterile Infiltrate vs. Microbial Keratitis

  • Clinical Metric Sterile Infiltrate (CLPU / CLARE) Infectious Microbial Keratitis (Bacterial / Fungal)
  • Location Peripheral / Limbal Central or Paracentral
  • Infiltrate Size Small (< 1.0 mm to 1.5 mm) Large (> 1.5 mm, often > 3.0 mm)

Epithelial Defect Small or intact (defect smaller than infiltrate) Extensive (defect matches or exceeds infiltrate)

  • Stromal Tissue Loss Minimal or none (flat surface) Deep stromal excavation, necrosis, thinning
  • Anterior Chamber Quiet (0 cell/flare; no hypopyon) Severe (≥ 2+ cell/flare; hypopyon present)
  • Pain Intensity Mild to Moderate; foreign body sensation Severe, unremitting, deep orbital ache
  • Discharge Watery or slight mucoid Copious mucopurulent / purulent discharge
  • Progression Static; improves immediately upon lens removal Rapidly progressive (worsens within hours)

Infectious Microbial Keratitis: Major Pathogens & Management

Infectious keratitis in contact lens wearers is an absolute ophthalmic emergency capable of causing permanent blindness, corneal scarring, and endophthalmitis.

1. Pseudomonas aeruginosa (Fulminant Gram-Negative Keratitis)

Pseudomonas aeruginosa is a motile, Gram-negative rod responsible for approximately 60% to 70% of contact lens-related bacterial ulcers .

Pathogenicity & Virulence: Pseudomonas adheres to soft contact lens polymers via pili. It secretes formidable virulence factors, including elastase (LasA, LasB), alkaline protease , and Exotoxin A . These enzymes rapidly digest corneal proteoglycans and type I collagen fibers while paralyzing host immune defenses.

Clinical Presentation: Fulminant corneal melting within 24 to 48 hours . Presents with an extensive, soupy, yellowish-green stromal infiltrate with copious mucopurulent discharge, ground-glass stromal edema, a severe anterior chamber reaction, and a dense hypopyon . Left untreated, rapid liquefactive necrosis precipitates descemetocele formation and globe perforation within 48 hours.

Emergency Treatment:

Immediate corneal scraping for Gram stain, Giemsa stain, and blood/chocolate/Sabouraud agar cultures.

Fortified Topical Antibiotics: Fortified tobramycin or gentamicin (14 mg/mL) alternating with fortified cefazolin (50 mg/mL) or vancomycin (25 to 50 mg/mL) , instilled every 15 to 30 minutes around the clock for the first 24 to 48 hours.

Alternatively, monotherapy with high-concentration fluoroquinolones ( besifloxacin 0.6%, moxifloxacin 0.5%, or ciprofloxacin 0.3% ) administered on a loading-dose protocol.

Cycloplegia with atropine 1% tid to relieve ciliary spasm and prevent posterior synechiae.

2. Acanthamoeba Keratitis (Protozoan Parasite)

Acanthamoeba is a ubiquitous, free-living protozoan that exists in two states: an active, motile trophozoite and a dormant, double-walled, highly resistant cyst that survives chlorination, desiccation, and freezing.

Primary Risk Factors: Contact lens exposure to tap water, hot tubs, swimming pools, lakes, or homemade saline solutions .

Clinical Hallmarks:

Severe Pain Out of Proportion to Findings: Patients complain of excruciating, unrelenting deep ocular pain that seems wildly disproportionate to modest early slit-lamp signs.

Radial Keratoneuritis: Infiltrates track along corneal nerves in the subepithelial and anterior stroma, visible as radial linear branching lines radiating from the limbus toward the central cornea.

Pseudodendrites: Epithelial irregularities mimic Herpes Simplex Virus (HSV) keratitis, but lack terminal bulbs and do not respond to acyclovir.

Classic Stromal Ring Infiltrate (Wessely Ring): Appears 3 to 6 weeks into infection as an immune ring of antigen-antibody complexes and inflammatory cells surrounding the central infected stroma.

Diagnostic Confirmation: In vivo confocal microscopy reveals hyperreflective, spherical double-walled cysts. Corneal scrapings plated on non-nutrient agar seeded with an Escherichia coli lawn show tracking trails as trophozoites consume bacteria.

Medical Therapy: Trophozoites and cysts are eradicated using cationic biguanides ( polyhexamethylene biguanide [PHMB] 0.02% or chlorhexidine 0.02% ) combined with diamidines ( propamidine isethionate 0.1% [Brolene] ), administered hourly day and night. Therapy must often continue for 6 to 12 months to prevent recrudescence from dormant cysts.

3. Fungal Keratitis (Fusarium, Aspergillus, Candida)

Etiology: Filamentous fungi ( Fusarium , Aspergillus ) historically associated with contact lens solution contamination (e.g., ReNu with MoistureLoc outbreak) and vegetative ocular trauma. Candida albicans (yeast) occurs primarily in immunocompromised eyes or chronic ocular surface disease.

Clinical Hallmarks:

Dry, elevated, grayish-white stromal infiltrate with feathery, indistinct margins .

Satellite lesions: Multiple discrete micro-infiltrates separated from the main ulcer by clear stroma.

Endothelial plaques beneath the ulcer and dense, thick hypopyons.

Diagnostic Staining: Gomori methenamine silver (GMS) and Calcofluor white stains show fungal hyphae.

Medical Therapy: Topical natamycin 5% suspension (drug of choice for filamentous Fusarium ), topical amphotericin B 0.15% to 0.5% (for Candida yeast), and oral/topical voriconazole 1% . Topical corticosteroids are strictly contraindicated!